All Stories

  1. Taste masked thin films printed by jet dispensing
  2. Inkjet printing of transdermal microneedles for the delivery of anticancer agents
  3. Bioinspired Titanium Drug Eluting Platforms Based on a Poly-β-cyclodextrin–Chitosan Layer-by-Layer Self-Assembly Targeting Infections
  4. Molecular Modeling as a Predictive Tool for the Development of Solid Dispersions
  5. Increased dissolution rates of carbamazepine – gluconolactone binary blends processed by hot melt extrusion
  6. An in-vitro-in-vivo taste assessment of bitter drug: comparative electronic tongues study
  7. SEM/EDX and confocal Raman microscopy as complementary tools for the characterization of pharmaceutical tablets
  8. Prediction of Polymorphic Transformations of Paracetamol in Solid Dispersions
  9. Development of sustained-release formulations processed by hot-melt extrusion by using a quality-by-design approach
  10. Continuous Cocrystallization for Dissolution Rate Optimization of a Poorly Water-Soluble Drug
  11. Continuous cocrystallisation of carbamazepine and trans-cinnamic acid via melt extrusion processing
  12. Sirolimus Encapsulated Liposomes for Cancer Therapy: Physicochemical and Mechanical Characterization of Sirolimus Distribution within Liposome Bilayers
  13. An in-vivo and in-vitro taste masking evaluation of bitter melt-extruded drugs
  14. Sustained release solid lipid matrices processed by hot-melt extrusion (HME)
  15. Diclofenac sodium sustained release hot melt extruded lipid matrices
  16. A review on the taste masking of bitter APIs: hot-melt extrusion (HME) evaluation
  17. Study of the Effect of Pressure on Melting Behavior of Saturated Fatty Acids in Liquid or Supercritical Carbon Dioxide
  18. Mechanism of synergistic interactions and its influence on drug release from extended release matrices manufactured using binary mixtures of polyethylene oxide and sodium carboxymethylcellulose
  19. Effect of glucosamine HCl on dissolution and solid state behaviours of piroxicam upon milling
  20. Prostate Cancer Targeting with 7E11-C5.3—CdS Bioconjugated Quantum Dots
  21. Nanosuspensions with Enhanced Drug Dissolution Rates of Poorly Water-Soluble Drugs
  22. Drug–polymer intermolecular interactions in hot-melt extruded solid dispersions
  23. Drug Delivery Strategies for Poorly Water-Soluble Drugs
  24. Hot-Melt Extrusion (HME): From Process to Pharmaceutical Applications
  25. Inclusion of Water Insoluble Drugs in Amorphous Silica Nanoparticles
  26. Nanoparticulate systems for encapsulation and release of ibuprofen and ketoprofen
  27. Mesoporous silica nanoparticles in nanotechnology
  28. Hot-Melt Extrusion: Pharmaceutical Applications
  29. Taste Masking Using Hot-Melt Extrusion
  30. Bioadhesion Properties of Polymeric Films Produced by Hot-Melt Extrusion
  31. Supplemental Images
  32. Dissolution enhancement of poorly water-soluble APIs processed by hot-melt extrusion using hydrophilic polymers
  33. Preparation and optimization of PMAA–chitosan–PEG nanoparticles for oral drug delivery
  34. Nano and microparticle engineering of water insoluble drugs using a novel spray-drying process
  35. Taste masking of paracetamol by hot-melt extrusion: An in vitro and in vivo evaluation
  36. A Review of Hot-Melt Extrusion: Process Technology to Pharmaceutical Products
  37. Development and evaluation of orally disintegrating tablets (ODTs) containing Ibuprofen granules prepared by hot melt extrusion
  38. The Influence of Sodium Carboxymethylcellulose on Drug Release from Polyethylene Oxide Extended Release Matrices
  39. Assessment of fluidity of different invasomes by electron spin resonance and differential scanning calorimetry
  40. Orally disintegrating dosage forms and taste-masking technologies; 2010
  41. In vitro and in silico investigations of drug delivery via zeolite BEA
  42. Mesoporous silica Nanoparticles as Drug Delivery System
  43. Novel Coating Technologies of Drug Eluting Stents
  44. Development and Evaluation of Cetirizine HCl Taste-Masked Oral Disintegrating Tablets
  45. Preparation and characterization of ibuprofen solid lipid nanoparticles with enhanced solubility
  46. Development of Solid Lipid Nanoparticles for Enhanced Solubility of Poorly Soluble Drugs
  47. A Facile Synthesis Route of Size Tunable CdS Quantum Dots with High Photoluminescence Yield
  48. Quantum dots synthesis and biological applications as imaging and drug delivery systems
  49. Controlled release from directly compressible theophylline buccal tablets
  50. Inclusion of poorly soluble drugs in highly ordered mesoporous silica nanoparticles
  51. The Application of Electrostatic Dry Powder Deposition Technology to Coat Drug-Eluting Stents
  52. Chitosan derivatives alter release profiles of model compounds from calcium phosphate implants
  53. Development and release mechanism of diltiazem HCl prolonged release matrix tablets
  54. In vitro release of bovine serum albumin from alginate/HPMC hydrogel beads
  55. In vitro–in vivo correlations of self-emulsifying drug delivery systems combining the dynamic lipolysis model and neuro-fuzzy networks
  56. Using a Modified Shepards Method for Optimization of a Nanoparticulate Cyclosporine A Formulation Prepared by a Static Mixer Technique
  57. Diameter-Selective Solubilization of Carbon Nanotubes by Lipid Micelles
  58. Enhanced dissolution of Oxcarbazepine microcrystals using a static mixer process
  59. Practical approaches of taste masking technologies in oral solid forms
  60. Drug Release from Differently Structured Monoolein/Poloxamer Nanodispersions Studied with Differential Pulse Polarography and Ultrafiltration at Low Pressure
  61. Physicochemical characterization of solid dispersions of three antiepileptic drugs prepared by solvent evaporation method
  62. Stable carbamazepine colloidal systems using the cosolvent technique
  63. Nano- and micro-particulate formulations of poorly water-soluble drugs by using a novel optimized technique
  64. Adaptive Neuro-Fuzzy Modeling of Poorly Soluble Drug Formulations
  65. Release study of drugs from liposomic dispersions using differential pulse polarography
  66. A POLAROGRAPHIC METHODOLOGY FOR CONTINUOUS NON-DESTRUCTIVE MONITORING OF DRUG RELEASE FROM LIPOSOMES
  67. Determination of liposomes drug retention capacity using differential pulse polarography: the case of chlorothiazide
  68. Simultaneous quantitative determination of diazepam and liposomes using differential pulse polarography